Literature DB >> 23032887

Risk of second cancers after photon and proton radiotherapy: a review of the data.

Torunn I Yock1, Paul A Caruso.   

Abstract

Control rates for pediatric and adult malignancies are now approximately 80 and 60%, respectively, due to dramatic improvements in surgery, chemotherapy, and radiotherapy. However, radiotherapy is responsible for many of the adverse late effects of treatment, which is now well documented in the literature. The most serious and life threatening side effect of radiotherapy that affects both children and adults is radiation-induced second primary cancers.

Entities:  

Mesh:

Year:  2012        PMID: 23032887     DOI: 10.1097/HP.0b013e3182609ba4

Source DB:  PubMed          Journal:  Health Phys        ISSN: 0017-9078            Impact factor:   1.316


  12 in total

1.  Outcomes and acute toxicities of proton therapy for pediatric atypical teratoid/rhabdoid tumor of the central nervous system.

Authors:  Susan L McGovern; M Fatih Okcu; Mark F Munsell; Nancy Kumbalasseriyil; David R Grosshans; Mary F McAleer; Murali Chintagumpala; Soumen Khatua; Anita Mahajan
Journal:  Int J Radiat Oncol Biol Phys       Date:  2014-10-11       Impact factor: 7.038

2.  Low- and middle-income countries can reduce risks of subsequent neoplasms by referring pediatric craniospinal cases to centralized proton treatment centers.

Authors:  Phillip J Taddei; Nabil Khater; Bassem Youssef; Rebecca M Howell; Wassim Jalbout; Rui Zhang; Fady B Geara; Annelise Giebeler; Anita Mahajan; Dragan Mirkovic; Wayne D Newhauser
Journal:  Biomed Phys Eng Express       Date:  2018-02-07

Review 3.  Proton therapy for paediatric CNS tumours - improving treatment-related outcomes.

Authors:  Vinai Gondi; Torunn I Yock; Minesh P Mehta
Journal:  Nat Rev Neurol       Date:  2016-05-20       Impact factor: 42.937

4.  Linear No-Threshold Model VS. Radiation Hormesis.

Authors:  Mohan Doss
Journal:  Dose Response       Date:  2013-05-24       Impact factor: 2.658

Review 5.  Charged particle therapy--optimization, challenges and future directions.

Authors:  Jay S Loeffler; Marco Durante
Journal:  Nat Rev Clin Oncol       Date:  2013-05-21       Impact factor: 66.675

Review 6.  Childhood Cancer: Occurrence, Treatment and Risk of Second Primary Malignancies.

Authors:  Sebastian Zahnreich; Heinz Schmidberger
Journal:  Cancers (Basel)       Date:  2021-05-26       Impact factor: 6.639

7.  Proton therapy for pediatric and adolescent esthesioneuroblastoma.

Authors:  John T Lucas; Matthew M Ladra; Shannon M MacDonald; Paul M Busse; Alison M Friedmann; David H Ebb; Karen J Marcus; Nancy J Tarbell; Torunn I Yock
Journal:  Pediatr Blood Cancer       Date:  2015-03-27       Impact factor: 3.838

8.  Radiation for ETMR: Literature review and case series of patients treated with proton therapy.

Authors:  Sergio Jaramillo; David R Grosshans; Nancy Philip; Ali Varan; Canan Akyüz; Mary Frances McAleer; Anita Mahajan; Susan L McGovern
Journal:  Clin Transl Radiat Oncol       Date:  2018-11-07

Review 9.  Secondary Malignancy Risk Following Proton Radiation Therapy.

Authors:  Bree R Eaton; Shannon M MacDonald; Torunn I Yock; Nancy J Tarbell
Journal:  Front Oncol       Date:  2015-11-26       Impact factor: 6.244

Review 10.  Clinical and Functional Assays of Radiosensitivity and Radiation-Induced Second Cancer.

Authors:  Mohammad Habash; Luis C Bohorquez; Elizabeth Kyriakou; Tomas Kron; Olga A Martin; Benjamin J Blyth
Journal:  Cancers (Basel)       Date:  2017-10-27       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.